openPR Logo
Press release

Asthma Drugs Market Predicted to Reach USD 37.62 Billion by 2032 | AstraZeneca, GSK plc, Merck & Co., Inc.

01-20-2025 07:48 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Asthma Drugs Market

Asthma Drugs Market

The Global Asthma Drugs Market reached US$ 25.72 billion in 2024 and is expected to reach US$ 37.62 billion by 2032, growing at a CAGR of 5.2% during the forecast period 2025-2032.

Asthma Drugs Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.

Get a Free Sample PDF copy of the report - https://datamintelligence.com/download-sample/asthma-drugs-market

The Asthma Drugs market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

The Asthma Drugs Market focuses on medications used to treat and manage asthma, a chronic respiratory condition. These drugs include bronchodilators, corticosteroids, leukotriene modifiers, and biologics that help control symptoms, prevent attacks, and improve lung function. The market is driven by the rising prevalence of asthma, advancements in drug formulations, and growing awareness of effective asthma management and treatment options.

Forecast Growth Projected:

The Global Asthma Drugs Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Asthma Drugs Market:

AstraZeneca, GSK plc, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Regeneron Pharmaceuticals, Inc., Sanofi, Amgen Inc., Covis Pharma, and Camber Pharmaceuticals, Inc. among others.

Segment Covered in the Asthma Drugs Market: By Drug Class: Inhaled Corticosteroids, Leukotriene Modifiers, Long-Acting Beta Agonists (LABAs), Quick-Relief Medications, Combination Inhalers, Biologics, Others.

By Route of Administration: Inhalation, Oral, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Industry Development:

In January 2024, AstraZeneca announced that AIRSUPRA (albuterol/budesonide) is now available by prescription in the United States. This medication, which received FDA approval, is designed for the as-needed treatment or prevention of asthma symptoms. It also helps prevent sudden severe breathing problems, commonly known as asthma attacks, in individuals aged 18 years and older.

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=asthma-drugs-market

Regional Break out:

The global Asthma Drugs Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Asthma Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Asthma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/asthma-drugs-market

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Asthma Drugs market?

➠ Who are the global key manufacturers of the Asthma Drugs Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Asthma Drugs market opportunities and threats faced by the vendors in the global Asthma Drugs Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Asthma Drugs market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asthma Drugs Market Predicted to Reach USD 37.62 Billion by 2032 | AstraZeneca, GSK plc, Merck & Co., Inc. here

News-ID: 3821763 • Views:

More Releases from DataM Intelligence 4Market Research

United States Evaporative Cooling Market Surges as Demand for Sustainable, Energy-Efficient Cooling Solutions Rises 2025 | Top key players - Baltimore Aircoil Company, Condair Group, Colt Group.
United States Evaporative Cooling Market Surges as Demand for Sustainable, Energ …
Market Size and Growth: The Global Evaporative Cooling Market size reached US$ 6.51 billion in 2023 and is expected to reach US$ 10.24 billion by 2031, growing with a CAGR of 5.83% during the forecast period 2024-2031. The Evaporative Cooling Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
United States Hybrid Power Solution Market Surges Ahead: Driving Energy Efficiency & Sustainable Growth 2025 | Top key players - General Electric Company, Eltek Ltd, Danvest BV.
United States Hybrid Power Solution Market Surges Ahead: Driving Energy Efficien …
Market Overview: The Hybrid Power Solution Market is expected to reach at a Significant CAGR during the forecast period (2024-2031). The Hybrid Power Solution Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Hybrid Power Solution market report is an essential resource
United States Next Generation Advanced Batteries Market Set to Revolutionize Global Energy Storage with Breakthrough Innovations 2025 | Top key players - Sion Power Corporation, LG Chem Ltd, Saft Groupe SA.
United States Next Generation Advanced Batteries Market Set to Revolutionize Glo …
Market Size and Growth: The Global Next Generation Advanced Batteries Market size reached US$1.95 billion in 2024 and is expected to reach US$3.41 billion by 2032, growing with a CAGR of 7.24% during the forecast period 2025-2032 The Next Generation Advanced Batteries Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for
United States Cogeneration Equipment Market Set for Strong Growth as Demand for Efficient Power Solutions Accelerates 2025 | Major key players - Rolls-Royce plc, Siemens, GE Vernova
United States Cogeneration Equipment Market Set for Strong Growth as Demand for …
Market Size and Growth: The Cogeneration Equipment Market reached US$29.91 billion in 2024 and is expected to reach US$52.24 billion by 2032, growing with a CAGR of 7.22% during the forecast period 2025-2032. The Cogeneration Equipment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase